about
The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistanceUse of a bacteriophage lysin to identify a novel target for antimicrobial developmentMolecular characterization of podoviral bacteriophages virulent for Clostridium perfringens and their comparison with members of the PicovirinaeCharacterization and determination of holin protein of Streptococcus suis bacteriophage SMP in heterologous hostNovel highly thermostable endolysin from Thermus scotoductus MAT2119 bacteriophage Ph2119 with amino acid sequence similarity to eukaryotic peptidoglycan recognition proteinsCholine Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New AntimicrobialsAntimicrobial bacteriophage-derived proteins and therapeutic applicationsAntibiotic alternatives: the substitution of antibiotics in animal husbandry?Bacteriophages and phage-derived proteins--application approachesPreclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredientPharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers.Bacteriophage endolysins as novel antimicrobials.Engineered bacteriophage lysins as novel anti-infectivesHolins in bacteria, eukaryotes, and archaea: multifunctional xenologues with potential biotechnological and biomedical applications.Thermal stability of Cpl-7 endolysin from the streptococcus pneumoniae bacteriophage Cp-7; cell wall-targeting of its CW_7 motifs.The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of miceBacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.Prediction of peptidoglycan hydrolases- a new class of antibacterial proteins.Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.Bioengineered probiotics, a strategic approach to control enteric infectionsCombination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.Rapid detection methods for Bacillus anthracis in environmental samples: a review.Bacteriophage based probes for pathogen detection.Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics.Peptidoglycan hydrolases-potential weapons against Staphylococcus aureusAntimicrobial enzymes: an emerging strategy to fight microbes and microbial biofilms.Antibacterial bioagents based on principles of bacteriophage biology: an overview.New perspectives on dietary-derived treatments and food safety-antinomy in a new era.Reduced Binding of the Endolysin LysTP712 to Lactococcus lactis ΔftsH Contributes to Phage Resistance.Bacteriophages and bacteriophage-derived endolysins as potential therapeutics to combat Gram-positive spore forming bacteria.Microbial approaches for targeting antibiotic-resistant bacteria.Models for the directed evolution of bacterial allelopathy: bacteriophage lysins.Dynamics of Mycobacteriophage-Mycobacterial Host Interaction: Evidence for Secondary Mechanisms for Host LethalityEC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis.Expression of Recombinant pET22b-LysK-Cysteine/Histidine-Dependent Amidohydrolase/Peptidase Bacteriophage Therapeutic Protein in Escherichia coli BL21 (DE3).Next generation sequencing technologies and the changing landscape of phage genomicsIn silico modeling of the staphylococcal bacteriophage-derived peptidase CHAP(K).The novel Shewanella putrefaciens-infecting bacteriophage Spp001: genome sequence and lytic enzymes.Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5.Bacteriophage-Derived Peptidase CHAP(K) Eliminates and Prevents Staphylococcal Biofilms.
P2860
Q21089782-39DDBAAC-6699-4DE3-9836-C0E74404C115Q21133592-B9593960-57D2-49B1-8142-B525DBA28B57Q21134546-B61E7A76-297A-4527-AE66-5A101B20EEE9Q21245089-6F4C8C53-A73B-44AC-9E9B-F46EDB82FC47Q24609778-FBFF3C7C-9CE7-4C30-A5D6-999D1CC1791CQ26744448-24359CF5-C21E-46FA-A4E6-CF751445F31CQ26781115-887B6EE6-4078-4B8E-A684-3A08AA48E454Q27027984-8EB13BE1-39F3-472E-8F7C-890825FD8EECQ28082731-C97C9C7C-E543-4A56-B7A1-D173FB772C53Q33622902-BAC68E5D-2CF5-479C-A56C-230F6736C56EQ33726692-3E9DE1B6-665C-4D16-94DF-37BC294DDD43Q34303439-426A53E6-F79D-4978-A58A-E44C558CC72EQ34349552-CAA46A21-FE8C-4247-B5B0-8432BECE44BFQ34435161-7D313230-1123-4CFA-8CED-0E76299FBD4CQ34441804-01E765B8-FD9B-45E9-B75C-38880AA417B6Q34664096-27B79730-0E0E-48E1-945A-09D12CBA66DDQ35963673-7DEE9D29-1B84-4B8E-8435-44AADE036AACQ36031358-1642C094-EFFB-4C87-B1FA-F6C2C6013D24Q36676044-5958A211-43A0-4AAB-8497-C550EA48329FQ37607761-89378DEA-726B-4D04-8BA3-154EA2E7B160Q37696606-E202DF57-5B5F-47B5-A757-90727E645499Q37977367-B81A3E5F-038A-43BF-8AFA-0F2C3D54F780Q38020842-B90DA339-559C-406C-BDF5-69487B7DC41AQ38044739-D845E8B6-A026-4A92-80DC-ECA624074EC6Q38053102-8FB844F7-2862-4B5C-B8E5-0E4B56F708FEQ38071062-70714D33-35A1-43A3-9578-3B2F809FA52CQ38165668-285BD74A-1AC7-4B97-B2D7-AB40273710B2Q38219163-F5F5008B-8AC7-41E9-B672-2F50FFF35813Q38363778-03CFA3B3-463F-4732-8F44-CF293C12A626Q38537430-1E2E18F6-C32E-42C5-9B84-92042BA3CD41Q38644054-C4E63B7F-0B50-4FFA-A446-87CF0827FD0FQ39531958-5ED28279-37F2-4F28-96D6-FD38A88573C8Q40948487-FFB778D2-DF43-43E2-92E2-A9CD3AEB355FQ41457130-05C55224-41AA-4F4B-A36E-079F11FBD419Q41601339-70183F4A-8260-437D-AA8D-9468850AD6E3Q41918953-7B4D0263-7E08-4E22-9E7E-ECBB70602411Q42055505-21B6D8F4-84E0-4E58-A86D-9E8E360AF6B4Q42223992-AE27E6DF-7F60-4005-9992-FA846AD7E073Q42583742-6BA5DCC3-F87A-40C6-B67B-125AFA210157Q43245858-AF1967B8-357E-41CA-903C-9B41274E034F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Recombinant bacteriophage lysins as antibacterials
@ast
Recombinant bacteriophage lysins as antibacterials
@en
Recombinant bacteriophage lysins as antibacterials
@nl
type
label
Recombinant bacteriophage lysins as antibacterials
@ast
Recombinant bacteriophage lysins as antibacterials
@en
Recombinant bacteriophage lysins as antibacterials
@nl
prefLabel
Recombinant bacteriophage lysins as antibacterials
@ast
Recombinant bacteriophage lysins as antibacterials
@en
Recombinant bacteriophage lysins as antibacterials
@nl
P2093
P2860
P356
P1433
P1476
Recombinant bacteriophage lysins as antibacterials
@en
P2093
Aidan Coffey
Jim O'Mahony
Mark Fenton
P2860
P356
10.4161/BBUG.1.1.9818
P577
2010-01-01T00:00:00Z